Prevalence and predictors of Sickle Cell Nephropathy A single-center experience Khaled Elzorkany Mortadah Alsalman Nawal Eltayeb Omer ResearchOpen Access15 Nov 2024Scientific Reports Volume: 14, P: 28215 Identification of genetic variants associated with clinical features of sickle cell disease ...
SICKLE cell anemiaSICKLE cell traitACQUISITION of dataBIBLIOGRAPHIC databasesSickle cell disease (SCD) is an inherited monogenic disorder with high prevalence throughout sub-Saharan Africa, the Mediterranean basin, the Middle East, and India. Sources of SCD epidemiology remain scarce and fragmented. A ...
Sickle Cell Disease Partnership In addition, we are proud to be founding member of the Sickle Cell Disease Partnership, which brings together members of the patient, provider and biopharmaceutical communities to advocate for policies that improve quality and access to care for the Sickle Cell ...
Dublin, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The"Sickle Cell Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access"report has been added toResearchAndMarkets.com'soffering. The Sickle Cell Disease...
Sickle Cell Disease Partnership In addition, we are proud to be founding member of the Sickle Cell Disease Partnership, which brings together members of the patient, provider and biopharmaceutical communities to advocate for policies that improve quality and access to care for the Sickle Cell ...
cell anemia / Sickle cell anemia / Sickle cell-hemoglobin SS disease (disorder) / Anemia sickle cell / Anemia, Sickle Cell / Sickle-cell/HB-C disease / Sickle-cell/Hb-C disease without crisis / Hemoglobin SC Disease / Sickle cell-hemoglobin C disease (disorder) / Sickle cell Hb-C ...
PRIMER Sickle cell disease Gregory J. Kato1, Frédéric B. Piel2, Clarice D. Reid3, Marilyn H. Gaston4, Kwaku Ohene‑Frempong5, Lakshmanan Krishnamurti6, Wally R. Smith7, Julie A. Panepinto8, David J. Weatherall9, Fernando F. Costa10 and Elliott P. Vichin...
Global Sickle Cell Disease Treatment Market: Trends and Opportunities The global market for sickle cell disease treatment has been chiefly driven due to the rising prevalence of these conditions in developing as well as developed economies of the globe. Moreover, the vast set of unmet needs in...
Sickle-cell disease. With the global scope of sickle-cell disease, knowledge of the countless clinical presentations and treatment of this disorder need to be familiar to gener... MJ Stuart,RL Nagel - 《Lancet》 被引量: 430发表: 2004年 First Ischemic Stroke in Sickle-Cell Disease: Are ...
Sickle Cell Disease (SCD) is recognized as the most prevalent severe genetic disorder due to its wide distribution and profound effects on those it affects. Despite being caused by a single gene mutation, it imposes considerable health challenges and mortality rates. Its impact is par...